CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in AKBA — Akebia Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in AKBA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,801,652
-$709,468 QoQ
Shares Held
2,015,577
-7.6% QoQ
Ownership
0.727%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,626,421,306 across 43 Drug Manufacturers - Specialty & Generic names. AKBA ranks #31 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,717,247 | $439,415,767 | |
| 2 | VTRS |
Viatris Inc
|
13,674,306 | $184,739,874 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
300,481 | $178,179,223 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
902,788 | $118,933,291 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,577,850 | $85,617,950 | |
| 6 | ALKS |
Alkermes plc.
|
2,236,756 | $79,091,692 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,087,679 | $62,880,891 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
657,413 | $49,864,776 |
All Filings in AKBA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,801,652 | 2,015,577 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,511,120 | 2,180,820 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,924,867 | 2,170,281 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,726,414 | 749,015 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,195,994 | 622,914 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $1,114,749 | 586,710 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $750,640 | 568,667 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $582,393 | 570,974 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $146,041 | 79,804 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $98,956 | 79,804 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $90,976 | 79,804 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $73,020 | 79,804 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $44,690 | 79,804 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $76,377 | 132,370 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $41,828 | 132,370 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $342,467 | 476,974 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,003,345 | 443,958 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,278,599 | 443,958 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $4,177,372 | 1,102,209 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,435,551 | 1,014,934 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,676,825 | 956,009 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,365,363 | 942,376 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $14,217,227 | 1,046,924 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $5,628,998 | 742,612 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||